2013 -
2014 Past President @ ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company
2009 -
2012 President @ ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company
2008 -
2009 Managing Director @ ImClone Systems International
2007 -
2008 CEO @
2006 -
2007 CEO @ Biopheresis GmbH
1998 -
2006 VP Therapeutic Area Oncology @
1986 -
1998 VP Medical Affairs; Head regionla office Asia @
Bernhard Ehmer Education
Ludwig-Maximilians Universität München / University of Munich
Heidelberg University
Bernhard Ehmer Skills
Oncology
Drug Development
Biotechnology
Biopharmaceuticals
Clinical Development
Pharmaceutical Industry
Clinical Trials
Medical Affairs
Technology Transfer
Drug Discovery
CRO
Lifesciences
Vaccines
GCP
Immunology
CTMS
Cancer
Regulatory Affairs
FDA
Life Sciences
Validation
GMP
Sop
21 CFR Part 11
Sales
Clinical Research
Healthcare
Microsoft Excel
Business Strategy
Bernhard Ehmer Summary
Bernhard Ehmer, based in Dreieich, HE, DE, is currently a Chairman of the Board of Directors at Biotest AG. Bernhard Ehmer brings experience from previous roles at Biotest AG, ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company and ImClone Systems International. Bernhard Ehmer holds a Ludwig-Maximilians Universität München / University of Munich. With a robust skill set that includes Oncology, Drug Development, Biotechnology, Biopharmaceuticals, Clinical Development and more. Bernhard Ehmer has 1 emails on RocketReach.
Get contact details of over 700M profiles across 60M companies - all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.